Document Detail


Fibrinolytic therapy for very late stent thrombosis--is it a viable option?
MedLine Citation:
PMID:  20934665     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Stent thrombosis (ST) has a very high case fatality and morbidity rates. The risk of very late ST is significantly increased with drug-eluting stents (DES) compared to bare-metal stents for at least up to 4 years. Discontinuation of clopidogrel therapy is the single most important consistently identified risk factor. Immediate reperfusion, preferably by primary percutaneous coronary intervention (PCI), has been considered the therapy of choice. Compared to de novo ST-elevation myocardial infarction (STEMI), myocardial infarction (MI) related to ST has significantly higher major adverse cardiovascular events (MACE) and lower reperfusion rates. Due to the significantly higher mortality associated with STEMI due to ST, prompt revascularization assumes paramount significance. Our case reflects the potential utility of fibrinolytic therapy for STEMI due to very late ST. Systemic fibrinolysis should be considered for ST in the presence of ongoing significant ischemia and unavailability of prompt PCI.
Authors:
Abdul Hakeem; Sabha Bhatti; Imran Arif; Mohamed Effat; Mehmet Cilingiroglu
Related Documents :
12081985 - Early resolution of st-segment elevation correlates with myocardial salvage assessed by...
17592205 - Misdiagnosis: cardiac metastasis presented as a pseudo-infarction on electrocardiography.
11781935 - The role of heart rate in myocardial ischemia from restricted coronary perfusion.
2590925 - Effects of heart rate and diltiazem hydrochloride on alternans of st segment elevation ...
15947895 - The role of aldosterone blockade in patients with heart failure.
3383375 - Influences of anisotropic tissue structure on reentrant circuits in the epicardial bord...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cardiovascular revascularization medicine : including molecular interventions     Volume:  11     ISSN:  1878-0938     ISO Abbreviation:  Cardiovasc Revasc Med     Publication Date:    2010 Oct-Dec
Date Detail:
Created Date:  2010-10-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101238551     Medline TA:  Cardiovasc Revasc Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  264.e13-5     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 Elsevier Inc. All rights reserved.
Affiliation:
Division of Cardiovascular Diseases, College of Medicine, University of Cincinnati, Cincinnati, OH 45257-0542, USA. ahakeem@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Acute renal artery thrombosis treated with t-PA power-pulse spray rheolytic thrombectomy.
Next Document:  Reduction of a previous atrial septostomy in a patient with end-stage pulmonary hypertension by a ma...